General Statement of Disclosure:
CONSULTING FEES/HONORARIA: New Amsterdam Pharma(MODEST) RESEARCH/RESEARCH GRANTS: Novartis Corporation(SIGNIFICANT), Amgen Inc.(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Esperion(SIGNIFICANT)
ACC.org and related websites will be offline for maintenance Monday, Nov. 9 at 8 p.m. until midnight ET. Your patience is appreciated as we work to enhance our systems.
CONSULTING FEES/HONORARIA: New Amsterdam Pharma(MODEST) RESEARCH/RESEARCH GRANTS: Novartis Corporation(SIGNIFICANT), Amgen Inc.(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Esperion(SIGNIFICANT)